Molecular recognition is required for numerous processes in chemistry, biology and engineering. One prominent example is enzyme--substrate (E--S) complex formation, which, as Koshland[@b1] proposed in 1958, may occur by \'induced fit\'. Enzyme active sites undergo dynamic recognition upon substrate binding, with E and S rapidly adopting complementary conformations tailored for enzyme catalytic function. Such molecular recognition depends on the size and shape of the enzyme host and substrate guest molecules, as well as on conformational flexibility[@b2][@b3][@b4][@b5]. The complexity of non-covalent host--guest interactions in natural supramolecular assemblies motivates our study of smaller synthetic systems.

Cryptophanes are widely investigated synthetic host molecules[@b6] whose internal volume can be varied by changing the length or composition of the three alkane linkers joining two [cyclotriguaiacylene](#annotation-232){ref-type="annotation"} ([CTG](#annotation-231){ref-type="annotation"}) units. The linkers form three pores, which control guest entry, serving as size- and shape-selective filters. Numerous solution studies have characterized the reversible binding of cryptophane hosts to small molecules[@b6]. The internal volume of [cryptophane-A](#annotation-230){ref-type="annotation"} with three [ethylene](#annotation-229){ref-type="annotation"} linkers was reported previously as either 81.5 Å^3^ (ref. [@b7]) or 95 Å^3^ (ref. [@b8]), on the basis of modelling studies. The spherical molecules [methane](#annotation-228){ref-type="annotation"} (28 Å^3^), [xenon](#annotation-227){ref-type="annotation"} (42 Å^3^) and [chloroform](#annotation-226){ref-type="annotation"} (72 Å^3^) gain entry, and span the range of accessible volumes. [Methane](#annotation-225){ref-type="annotation"} binds to [cryptophane-A](#annotation-224){ref-type="annotation"} with a relatively large association constant compared with other host molecules, *K*~A~=130 M^−1^ at 298 K in [C2D2Cl4](#annotation-223){ref-type="annotation"} (ref. [@b7]). Under these conditions, similar binding to [crytophane-A](#annotation-222){ref-type="annotation"} occurs with [chloroform](#annotation-221){ref-type="annotation"}, *K*~A~=230 M^−1^ (ref. [@b7]), and by far the highest affinity has been measured for [xenon](#annotation-220){ref-type="annotation"}, *K*~A~=3,900 M^−1^ (ref. [@b9]). The preference for [xenon](#annotation-219){ref-type="annotation"} has been a mystery: using the available [chloroform](#annotation-218){ref-type="annotation"}--[cryptophane-A](#annotation-217){ref-type="annotation"} structures[@b10] as a template, the [Xe](#annotation-216){ref-type="annotation"} atom is predicted to underfill the cavity.

To date, [cryptophanes-A](#annotation-215){ref-type="annotation"}[@b10] and -E[@b11] have only been crystallized with [chloroform](#annotation-214){ref-type="annotation"}, and [cryptophanes-C](#annotation-213){ref-type="annotation"} and -D have been crystallized with [dichloromethane](#annotation-212){ref-type="annotation"}[@b12][@b13]. Cavagnat *et al.*[@b10] obtained small crystals of the [CDCl3](#annotation-211){ref-type="annotation"}--[cryptophane-A](#annotation-210){ref-type="annotation"} complex in three different morphologies (rhombic, rod-like and polyhedral) and these were structurally determined by X-ray diffraction and studied by Raman microspectrometry. However, no small-molecule X-ray structure of a xenon--cryptophane complex has been reported. Providing some precedent are crystal structures of [xenon](#annotation-209){ref-type="annotation"} bound to calixarene[@b14][@b15] and cucurbit\[5\]uril[@b16] hosts. Also relevant are protein X-ray crystal structure determinations in which [xenon](#annotation-208){ref-type="annotation"} was used as a heavy atom to improve phasing[@b17]. Finally, we reported a 1.7-Å resolution macromolecular crystal structure of a [xenon](#annotation-207){ref-type="annotation"} biosensor bound to carbonic anhydrase II, which indicated electron density corresponding to a single [xenon](#annotation-206){ref-type="annotation"} atom bound within the cryptophane[@b18].

There is growing interest in functionalized [cryptophane-A](#annotation-205){ref-type="annotation"} derivatives based on the significant potential of hyperpolarized [129Xe](#annotation-204){ref-type="annotation"} for biodetection and biomolecular imaging[@b19][@b20]. Recently, MS2 virus capsid decorated with 125 cryptophanes was detected at sub-picomolar concentrations by hyperpolarized [129Xe](#annotation-203){ref-type="annotation"} nuclear magnetic resonance (NMR) spectroscopy[@b21]. Using a tripropargyl-derivatized [cryptophane-A](#annotation-202){ref-type="annotation"}, our laboratory synthesized cryptophane-benzenesulfonamide biosensors that produced [129Xe](#annotation-201){ref-type="annotation"} NMR chemical shift differences of 3.0--7.5 p.p.m. on binding carbonic anhydrase isozymes[@b22]. We also generated peptide-modified cryptophane that was delivered to human cancer cell lines[@b23].

A triacetate-functionalized [cryptophane-A](#annotation-200){ref-type="annotation"}[@b24] shows the highest [xenon](#annotation-199){ref-type="annotation"} affinity of any host molecule, *K*~A~=3.3×10^4^ M^−1^ at 293 K in buffer. The higher affinity of [xenon](#annotation-198){ref-type="annotation"} for cryptophane in [water](#annotation-197){ref-type="annotation"} results from entropic (\'hydrophobic\') effects that likely involve desolvation of [xenon](#annotation-196){ref-type="annotation"} clathrates upon complexation. We have also hypothesized that [cryptophane-A](#annotation-195){ref-type="annotation"} adopts a more compact shape in [water](#annotation-194){ref-type="annotation"}, which should increase favourable van der Waals contacts with [xenon](#annotation-193){ref-type="annotation"}[@b24]. Although conformational flexibility of the three alkoxy linkers has been observed in solution previously[@b9][@b25][@b26], until now, there has been little evidence of volume changes in the \'open\' crown--crown (CC) conformation of [cryptophane-A](#annotation-192){ref-type="annotation"}, and this is often considered as a fixed cavity.

Synthetic host binding sites have also been investigated with macrocyclic compounds such as cyclodextrins, crown ethers and cyclophanes[@b27][@b28]. Cyclodextrin studies suggest that the guest inclusion process is influenced by hydrophobic interactions, as well as by the shape and size of the guest[@b28]. Recently, crystallographic studies revealed changes in [β-cyclodextrin](#annotation-191){ref-type="annotation"} conformation upon [quinine](#annotation-190){ref-type="annotation"} encapsulation[@b29].

Here, we report X-ray crystal structures showing analogous induced fit in a cryptophane host--guest model system. Unlike many small-molecule host systems that have been characterized crystallographically to date, cryptophanes contain a three-dimensional hydrophobic cavity, which approximates many enzyme active sites. Because of minimal electrostatic interactions in these host--guest complexes, cryptophane binding is driven by favourable London forces. [Cryptophane-A](#annotation-189){ref-type="annotation"}, tripropargyl (**1**) and triallyl (**2**) derivatives ([Fig. 1](#f1){ref-type="fig"}) were crystallized with various encapsulated hydrophobic guests, including [xenon](#annotation-188){ref-type="annotation"}. Notably, the cryptophane internal volume increased by more than 20% as the guest volume increased from [methanol](#annotation-187){ref-type="annotation"} to [chloroform](#annotation-186){ref-type="annotation"}.

Results
=======

Crystallization parameters
--------------------------

For crystallization of cryptophane--guest complexes, it was necessary to avoid solvents that compete for binding inside the cryptophane cavity. [Fluorobenzene](#annotation-185){ref-type="annotation"} is a sterically bulky solvent that adequately solubilizes **1** and **2** to allow for crystal growth by vapour diffusion of [diethyl ether](#annotation-184){ref-type="annotation"} or [n-pentane](#annotation-183){ref-type="annotation"}. [Cryptophane-A](#annotation-182){ref-type="annotation"}, **1** and **2** as racemic mixtures cocrystallized with [xenon](#annotation-181){ref-type="annotation"} exhibited the CC conformation ([Fig. 2a,c,e](#f2){ref-type="fig"}). Moreover, in the absence of suitable guests, the crystal structure of **1** revealed cryptophane in the CC conformation ([Fig. 2d](#f2){ref-type="fig"}), in agreement with solution ^1^H NMR data. Either without guests or with [xenon](#annotation-180){ref-type="annotation"}, **1** crystallized in the triclinic space group P1. The chirality of [cryptophane-A](#annotation-179){ref-type="annotation"} arises from the anti relationship of the methoxy groups relative to the ethylene oxide bridges, as was also observed in previous cryptophane X-ray structures[@b6][@b11].

Complexed and collapsed cryptophane structures
----------------------------------------------

Crystal structures of [cryptophane-A](#annotation-178){ref-type="annotation"}, **1** and **2** with [xenon](#annotation-177){ref-type="annotation"} as guest ([Fig. 2a,c,e](#f2){ref-type="fig"}) revealed, as expected, one [Xe](#annotation-176){ref-type="annotation"} atom centrally located within the cryptophane cavity. From the calculated Xe-carbon atom distances at the phenyl rings in the [Xe](#annotation-175){ref-type="annotation"}-**2** complex (range=4.03--4.73 Å, average=4.31 Å, [Supplementary Table S1)](#S1){ref-type="supplementary-material"}, it is evident that [Xe](#annotation-174){ref-type="annotation"} is positioned near the optimal distance from [CTG](#annotation-173){ref-type="annotation"} units: van der Waals interaction distance for [Xe](#annotation-172){ref-type="annotation"} and phenyl carbon is 3.86 Å[@b30] (where steric repulsion and favourable induced dipolar interaction are balanced).

We also report the first X-ray structure of [cryptophane-A](#annotation-171){ref-type="annotation"} cocrystallized with [water](#annotation-170){ref-type="annotation"} ([Fig. 2b](#f2){ref-type="fig"}). The cryptophane--[water](#annotation-169){ref-type="annotation"} structure was found to encapsulate one [water](#annotation-168){ref-type="annotation"} molecule containing partial electron density from the [water](#annotation-167){ref-type="annotation"} oxygen atom occupying seven different positions within the cavity. This disordered arrangement is consistent with \'bound\' [water](#annotation-166){ref-type="annotation"} not being observed at room temperature by solution ^1^H NMR spectroscopy. It is relevant that molecular dynamics simulations previously identified an average of only ∼2.1 [water](#annotation-165){ref-type="annotation"} molecules within the somewhat larger cryptophane-E cavity[@b31].

A crystal structure was obtained for **2** in a \'collapsed\' crown--saddle (CS) conformation ([Fig. 2f](#f2){ref-type="fig"}). CS-**2** crystallized in the monoclinic space group P2~1~/n with two of the allyl groups observed in two different possible orientations. This experimentally determined structure appears to agree with the one calculated previously by Huber *et al.*[@b32] The *C*~1~ symmetric structure of CS-**2** ([Fig. 2f](#f2){ref-type="fig"}) shows the bridging methylene pointing into the cavity. Although CS-**2** is the first crystal structure of the CS conformer of a [cryptophane-A](#annotation-164){ref-type="annotation"} derivative, a related CS conformer of a cryptophane possessing *m*-xylyl linkers between the [CTG](#annotation-163){ref-type="annotation"} units was previously studied by solution ^1^H NMR spectroscopy and single crystal X-ray diffraction by Mough *et al.*[@b33]. Although it is expected that CS**-2** is destabilized relative to the crown form of [CTG](#annotation-162){ref-type="annotation"} by 3--4 kcal mol^−1^ (ref. [@b34]), we conclude that crystal packing forces on **2** in the absence of guest can promote the CS conformation in the solid state. Interestingly, the allyl-substituted [CTG](#annotation-161){ref-type="annotation"} of CS-**2** retained its crown conformation, whereas the methoxy-substituted [CTG](#annotation-160){ref-type="annotation"} assumed the saddle conformation. The crystal structure of CS-**2** suggests that tri-substituted [cryptophane-A](#annotation-159){ref-type="annotation"} derivatives can access this energetically less stable, non-xenon-binding conformer in solution as well, as we previously proposed for [water](#annotation-158){ref-type="annotation"}-soluble [cryptophane-A](#annotation-157){ref-type="annotation"} derivatives[@b24] and as observed for hexa-acid [cryptophane-A](#annotation-156){ref-type="annotation"} derivatives[@b32].

Cryptophane host--guest volume calculations
-------------------------------------------

Mecozzi and Rebek surveyed many host--guest interactions mediated by London forces and determined empirically that optimal binding occurs when the guest occupies 55±9% of the host interior volume[@b8]. In cryptophane host systems in organic solution and [water](#annotation-155){ref-type="annotation"}, it has been established that the lengths and conformations of the alkoxy linkers connecting the two [CTG](#annotation-154){ref-type="annotation"} units regulate the size of the internal cavity, which in turn affects the [Xe](#annotation-153){ref-type="annotation"} binding constant[@b32][@b35]. For example, a smaller [cryptophane-1,1,1](#annotation-152){ref-type="annotation"} was synthesized[@b36] with an approximate internal volume of 81 Å^3^, making the volume ratio of the [xenon](#annotation-151){ref-type="annotation"} guest to the host cavity equal to ∼0.52. In this case, the [xenon](#annotation-150){ref-type="annotation"} association constant, *K*~A~=10,000 M^−1^ at 298 K in [(CDCl2)2](#annotation-149){ref-type="annotation"} (ref. [@b36]), was determined to be almost threefold higher than that for [cryptophane-A](#annotation-148){ref-type="annotation"}. [Xenon](#annotation-147){ref-type="annotation"} binding may be nearly optimized for the cavity in [cryptophane-1,1,1](#annotation-146){ref-type="annotation"}, although, without crystal structures, the [Xe](#annotation-145){ref-type="annotation"} packing fraction can only be approximated for this host--guest complex.

To investigate systematically the manner in which the size of the guest molecule influences the cryptophane cavity, we determined structures of the readily crystallized triallyl cryptophane **2** with [MeOH](#annotation-144){ref-type="annotation"}, [Xe](#annotation-143){ref-type="annotation"} and [CDCl3](#annotation-142){ref-type="annotation"}. The internal volumes of **2** in these complexes were calculated with Swiss Pdb Viewer[@b37] after deleting the encapsulated guest from the pdb files ([Table 1](#t1){ref-type="table"}). Although crystal packing forces undoubtedly have an effect on the observed molecular conformations, the fact that **2**--guest complexes all crystallized in the monoclinic space group P2~1~/c facilitates comparisons between the different structures. In contrast, we were unable to find an internal void volume for CS-**2**, as the collapsed cavity was too small to accommodate a 1.4 Å diameter probe.

As can be seen in [Table 1](#t1){ref-type="table"}, the internal volume of **2** increased by a remarkable 21%, from 84 to 102 Å^3^ as the size of the guest molecule increased from [MeOH](#annotation-141){ref-type="annotation"} to [CDCl3](#annotation-140){ref-type="annotation"}. The guest packing coefficient (defined as guest volume divided by host internal volume) increased even more dramatically across this series, 0.39→0.73. Importantly, [cryptophane-A](#annotation-139){ref-type="annotation"}, **1** and **2**---with different peripheral substituents---exhibited very similar cavity volumes for the same guest. Thus, it was possible to compare crystallographic data for these three cryptophane hosts. [Xenon](#annotation-138){ref-type="annotation"} bound to [cryptophane-A](#annotation-137){ref-type="annotation"}, **1** and **2** gave similar cavity volumes (85--89 Å^3^) and packing coefficients (0.47--0.49, [Table 1](#t1){ref-type="table"}). [Cryptophane-A](#annotation-136){ref-type="annotation"} adopts an intermediate-volume conformation for [Xe](#annotation-135){ref-type="annotation"}, which brings the packing fraction close to Rebek\'s empirically determined value. This presumably achieves a favourable balance of enthalpic and entropic forces and contributes to high [Xe](#annotation-134){ref-type="annotation"} affinity. Notably, an overlay of the CC-**1** and **1**-[Xe](#annotation-133){ref-type="annotation"} structures showed virtually no change induced by [Xe](#annotation-132){ref-type="annotation"} encapsulation (see [Supplementary Fig. S1](#S1){ref-type="supplementary-material"}). This provides further evidence that the [cryptophane-A](#annotation-131){ref-type="annotation"} structure is nearly optimal for [Xe](#annotation-130){ref-type="annotation"} binding.

[Figure 3](#f3){ref-type="fig"} illustrates how [xenon](#annotation-129){ref-type="annotation"} is sandwiched by three pairs of phenyl rings belonging to the two opposing [CTG](#annotation-128){ref-type="annotation"} units. As noted previously, many of the phenyl carbon atoms nearly achieve van der Waals contact with [Xe](#annotation-127){ref-type="annotation"}. In contrast, the Xe-C distances at the linkers are larger (range=4.54--5.41 Å, average=5.00 Å, [Supplementary Table S1](#S1){ref-type="supplementary-material"}), when the van der Waals interaction distance for [Xe](#annotation-126){ref-type="annotation"} and tetrahedral carbon is 4.16 Å[@b30]. The flexible [ethylene](#annotation-125){ref-type="annotation"} linkers reside farther away ([Fig. 3](#f3){ref-type="fig"}) and interact more weakly with [Xe](#annotation-124){ref-type="annotation"}, on average, but provide the [CTG](#annotation-123){ref-type="annotation"} units with mobility to accommodate [Xe](#annotation-122){ref-type="annotation"} in the cavity and optimize Xe--phenyl interactions.

Unlike [xenon](#annotation-121){ref-type="annotation"}, [MeOH](#annotation-120){ref-type="annotation"} clearly underfills the cryptophane cavity, with packing coefficient 0.39 ([Table 1](#t1){ref-type="table"}). Importantly, [MeOH](#annotation-119){ref-type="annotation"} is very similar in size to [methane](#annotation-118){ref-type="annotation"}, which is the smallest molecule the binding of which has been characterized for [cryptophane-A](#annotation-117){ref-type="annotation"}[@b7]. On the basis of the low packing coefficient for this smallest guest, it appears to be energetically unfavourable for the cavity to shrink to less than 84 Å^3^, as found in the [MeOH](#annotation-116){ref-type="annotation"} structure. Crystal packing forces may also have a role in stabilizing the conformation of cryptophane in the [MeOH](#annotation-115){ref-type="annotation"} structure.

The other exception to Rebek\'s \'55% solution\'[@b8] involves [CDCl3](#annotation-114){ref-type="annotation"}, which at 72 Å^3^ has the potential to fill the cryptophane cavity almost entirely. In fact, the cryptophane volume expanded to 102 Å^3^ in the **2**-[CDCl3](#annotation-113){ref-type="annotation"} structure, which reduced the entropic penalty but still yielded a large packing coefficient of 0.73.

Cavagnat *et al.*[@b10] determined that the chlorine atoms of [chloroform](#annotation-112){ref-type="annotation"} occupy the central equatorial plane of [cryptophane-A](#annotation-111){ref-type="annotation"}, and the C--H bond is collinear with the *C*~3~ axis of the cryptophane molecule. A similar orientation of chlorine atoms was observed for the larger cryptophane-E host, in which the C--H bond points either up or down along the pseudo *C*~3~ axis, towards one of the [CTG](#annotation-110){ref-type="annotation"} units[@b11]. For **2**-[CDCl3](#annotation-109){ref-type="annotation"}, we observed a similar orientation of the guest, with the deuterium directed to the centre of the allyl-modified [CTG](#annotation-108){ref-type="annotation"} (see [Supplementary Fig. S2](#S1){ref-type="supplementary-material"}). We reviewed the previously deposited [chloroform](#annotation-107){ref-type="annotation"}-bound [cryptophane-A](#annotation-106){ref-type="annotation"} structures in the three different crystal morphologies (rhombic, rod-like and polyhedral; CSD ref. codes IYEVEN, IYETUB and IYEVAJ)[@b10], but were unable to reliably calculate the volume of [cryptophane-A](#annotation-105){ref-type="annotation"}, or identify meaningful conformational differences between these structures, because of a high degree of molecular disorder. To a coarse approximation, similarly large cavities were identified for the three different structures, with expanded volumes consistent with the **2**-[CDCl3](#annotation-104){ref-type="annotation"} structure.

Cryptophane conformational changes seen for induced fit
-------------------------------------------------------

By overlaying the computed cavities for **2**-[MeOH](#annotation-103){ref-type="annotation"} and **2**-[CDCl3](#annotation-102){ref-type="annotation"}, it is evident that [CDCl3](#annotation-101){ref-type="annotation"} binding induces the cavity to expand from the centre of mass ([Supplementary Fig. S3](#S1){ref-type="supplementary-material"}). The crystallographic data indicate that the cavity can adapt to fit the encapsulated guest molecule. How does this \'induced fit\' occur?

Overlaid structures of **2**, complexed with [MeOH](#annotation-100){ref-type="annotation"} and [CDCl3](#annotation-99){ref-type="annotation"} ([Fig. 4](#f4){ref-type="fig"}), provide clear indication that the internal volume of [cryptophane-A](#annotation-98){ref-type="annotation"} is controlled by the three O-CH~2~-CH~2~-O linkers connecting the [CTG](#annotation-97){ref-type="annotation"} units. We used CrystMol 2.1 (ref. [@b38]) to superimpose the carbon backbone structures of **2** with bound [MeOH](#annotation-96){ref-type="annotation"} and [CDCl3](#annotation-95){ref-type="annotation"}, as these guests produced the largest difference in host cavity volume ([Table 1](#t1){ref-type="table"}). The superimposed cryptophane structures show the smaller **2-**[MeOH](#annotation-94){ref-type="annotation"} structure ([Fig. 4](#f4){ref-type="fig"}, grey carbon backbone) residing mostly inside the pink carbon backbone representing **2**-[CDCl3](#annotation-93){ref-type="annotation"}. The structures can be aligned such that one of the ethylenedioxy linkers (labelled O~(2)~-C~(46)~H~2~-C~(47)~H~2~-O~(3)~) is almost unchanged. However, linker O~(8)~-C~(56)~H~2~-C~(57)~H~2~-O~(9)~ in the **2**-[CDCl3](#annotation-92){ref-type="annotation"} complex is partly expanded such that the O~(8)~-O~(8)~ and C~(56)~-C~(56)~ distances between the two structures differ by 0.56 and 0.65 Å, respectively. An even more pronounced change is seen for the third linker, (O~(5)~-C~(51)~H~2~-C~(52)~H~2~-O~(6)~); O~(6)~-O~(6)~ and C~(52)~-C~(52)~ distances differ by 0.89 and 1.06 Å ([Fig. 4](#f4){ref-type="fig"}, [Supplementary Table S2](#S1){ref-type="supplementary-material"}). These data show that [cryptophane-A](#annotation-91){ref-type="annotation"} can expand both horizontally and vertically upon binding the larger [chloroform](#annotation-90){ref-type="annotation"} guest, moving the [CTG](#annotation-89){ref-type="annotation"} units farther apart by as much as 0.4 Å.

In this crystallographic study, we also examined geometrical parameters of the ethylenedioxy linkers that changed during the guest-binding process. In contrast with previous solution spectroscopic studies[@b9][@b25][@b26], ethylenedioxy linkers exhibited mixed anti and gauche conformations in the solid state. This determination was based on measured dihedral angles (**Θ1**, **Θ2**, **Θ3**) for all three linkers from the perspective of the \'north\' pole of the cryptophane, as defined by [CTG](#annotation-88){ref-type="annotation"} with allyl substituents ([Fig. 5](#f5){ref-type="fig"}). By increasing the guest volume from [MeOH](#annotation-87){ref-type="annotation"} to [CDCl3](#annotation-86){ref-type="annotation"}, the most dramatic change was observed for the linker labelled O~(5)~-C~(51)~H~2~-C~(52)~H~2~-O~(6)~: the conformation changed from gauche to anti with the dihedral angle decreasing from 74.5° to −171.7° ([Table 2](#t2){ref-type="table"}). Such linker transformations allow the increased vertical distance between [CTG](#annotation-85){ref-type="annotation"} units observed for [chloroform](#annotation-84){ref-type="annotation"} encapsulation ([Supplementary Table S2](#S1){ref-type="supplementary-material"}), and also allow the cavity to expand horizontally upon binding this largest guest. The superimposition of cryptophane structures with different sized guests, in addition to calculated internal volumes and dihedral angles, indicate how [cryptophane-A](#annotation-83){ref-type="annotation"} can accommodate guests of varied shape and size.

Discussion
==========

Previously unstudied in the solid state, xenon--cryptophane association was shown earlier in solution studies to depend on many factors, including the size, shape, rigidity, accessibility and polarity of the cage, as well as solvent. In particular, the [Xe](#annotation-82){ref-type="annotation"}--[cryptophane-A](#annotation-81){ref-type="annotation"} binding interaction has been studied by several experimental techniques including isothermal titration calorimetry, electronic circular dichroism, vibrational circular dichroism (VCD), NMR, as well as infrared and fluorescence spectroscopies[@b9][@b25][@b35][@b39][@b40][@b41][@b42]. [129Xe](#annotation-80){ref-type="annotation"} NMR chemical shift varies considerably in different cryptophane environments and solvents[@b19][@b20], but requires further benchmarking before it can be used to illuminate [Xe](#annotation-79){ref-type="annotation"}--cryptophane interactions. Spin polarization-induced nuclear Overhauser effect measurements can estimate xenon--proton internuclear distances for cryptophane in solution, on the basis of site-selective ^1^H NMR enhancements from hyperpolarized [129Xe](#annotation-78){ref-type="annotation"} (ref. [@b40]); however, crystal structures should allow more accurate distance assignments.

Interestingly, the packing fraction of 0.73 determined for the **2**-[CDCl3](#annotation-77){ref-type="annotation"} structure is consistent with the closest packing arrangement of uniform spheres, in which the fraction of space occupied by the spheres is 0.74. A packing fraction of 0.73 suggests a nearly maximal internal volume for the cryptophane, particularly as no guest larger than [chloroform](#annotation-76){ref-type="annotation"} has been reported to be encapsulated by [cryptophane-A](#annotation-75){ref-type="annotation"} in solution. The expanded (102 Å^3^) cavity volume observed for **2**-[CDCl3](#annotation-74){ref-type="annotation"} stands in contrast to the 82 Å^3^ volume reported for the previous [cryptophane-A](#annotation-73){ref-type="annotation"}--[chloroform](#annotation-72){ref-type="annotation"} crystal structures[@b10], although this value appears to be approximated. The calculation of crystallographically determined molecular cavity volumes and the observed expansion of the cryptophane cage upon binding larger guests are useful for addressing important issues first raised by Collet and co-workers[@b7] about the atomic densities and pressures that can be achieved in non-covalent cryptophane--guest complexes.

Previous solution studies showed that encapsulation of guests by [cryptophane-A](#annotation-71){ref-type="annotation"} can induce conformational changes in ethylenedioxy linkers[@b9][@b25][@b26][@b43]. For example, chiroptical changes observed by VCD and electronic circular dichroism indicated that [cryptophane-A](#annotation-70){ref-type="annotation"} ethylenedioxy linkers adopt an all-anti conformation upon encapsulation of bulky guests such as [chloroform](#annotation-69){ref-type="annotation"}[@b25]. Moreover, experimental and simulated VCD spectra suggested a preferential gauche linker conformation when [cryptophane-A](#annotation-68){ref-type="annotation"} is without any guests or bound to smaller guests[@b26]. ^1^H NMR spectroscopy also indicated that OCH~2~CH~2~O linkers adopt a gauche conformation in the [Xe](#annotation-67){ref-type="annotation"}--[cryptophane-A](#annotation-66){ref-type="annotation"} complex[@b9]. Contrary to these solution studies, we observed a mixture of both gauche and anti linker conformations in all cryptophane crystal structures, except for the all-gauche CS-**2** collapsed structure. In the CC cryptophane structures, the linker conformations were not correlated with the presence of guests or guest volume.

This crystallographic study improves understanding of the prototypal cryptophane host and related cavity-containing organic host molecules, which are often assumed to adopt conformations with a narrow range of cavity volumes. This is also relevant for [xenon](#annotation-65){ref-type="annotation"} biosensing applications, as manipulating the cryptophane cavity can produce significant changes in [xenon](#annotation-64){ref-type="annotation"} affinity and [129Xe](#annotation-63){ref-type="annotation"} NMR chemical shift. Finally, London forces are important to all molecular interactions in Nature, but are often difficult to elucidate because of their small magnitude (typically \<2 kJ mol^−1^) and the predominance of electrostatic interactions. The study of model host--guest systems using X-ray crystallography is useful for elucidating the role of weak interactions in molecular recognition.

In conclusion, we report the first crystal structures of [cryptophane-A](#annotation-62){ref-type="annotation"} and derivatives without guests in CC and CS conformations, as well as in complexes with [chloroform](#annotation-61){ref-type="annotation"}, [xenon](#annotation-60){ref-type="annotation"}, [methanol](#annotation-59){ref-type="annotation"} and [water](#annotation-58){ref-type="annotation"}. A crystallographic analysis revealed that these cryptophanes can undergo \'induced fit\' to improve guest binding interactions; the internal volume of the host varied by more than 20% to accommodate a wide range of hydrophobic guests. The ethylenedioxy linkers of [cryptophane-A](#annotation-57){ref-type="annotation"} confer conformational flexibility that allows both vertical and lateral changes to the cavity, for adaptation to guests ranging in volume from [MeOH](#annotation-56){ref-type="annotation"} (33 Å^3^) to [CDCl3](#annotation-55){ref-type="annotation"} (72 Å^3^). Of particular interest are xenon-bound structures, which identify nearly optimized van der Waals interactions between [xenon](#annotation-54){ref-type="annotation"} and the [CTG](#annotation-53){ref-type="annotation"} phenyl moieties.

Methods
=======

Synthesis
---------

[Cryptophane-A](#annotation-52){ref-type="annotation"} was obtained by seven-step synthesis with an overall yield of 4.4% (ref. [@b44]). Tripropargyl (**1**) and triallyl (**2**) cryptophane derivatives were synthesized according to published procedures in 9 and 10 steps with an overall yield of 4.9 and 2.9%, respectively[@b24][@b45].

Crystal growth
--------------

[Cryptophane-A](#annotation-51){ref-type="annotation"} and compounds **1** and **2** were each crystallized as a racemic mixture, with guests ([H2O](#annotation-50){ref-type="annotation"}, [MeOH](#annotation-49){ref-type="annotation"}, [Xe](#annotation-48){ref-type="annotation"}, [CDCl3](#annotation-47){ref-type="annotation"}) or without guests, by slow evaporation or by vapour diffusion of [diethyl ether](#annotation-46){ref-type="annotation"}, [n-pentane](#annotation-45){ref-type="annotation"} or hexanes into different solvents. Single crystals were grown in [CDCl3](#annotation-44){ref-type="annotation"} by slow evaporation, whereas crystals of [MeOH](#annotation-43){ref-type="annotation"} included within the cryptophane cavity were grown by vapour diffusion. [Fluorobenzene](#annotation-42){ref-type="annotation"} was chosen as solvent to grow cryptophane-xenon crystals as it is too large to occupy the cavity of the cryptophane and exhibits enough solubility towards cryptophanes to allow for the growth of a single crystal by vapour diffusion technique. The [fluorobenzene](#annotation-41){ref-type="annotation"} solution of cryptophane was degassed with static vacuum and bubbled with [Xe](#annotation-40){ref-type="annotation"} gas. The precipitating solvent ([diethyl ether](#annotation-39){ref-type="annotation"}, [n-pentane](#annotation-38){ref-type="annotation"} or hexanes) was also bubbled with [Xe](#annotation-37){ref-type="annotation"} and the headspace of the vapour diffusion vial was purged with [Xe](#annotation-36){ref-type="annotation"} before it was sealed. Single crystals of \'collapsed\' CS-**2** were obtained by means of dissolution in hot [mesitylene](#annotation-35){ref-type="annotation"}, cooling to room temperature and subjecting to vapour diffusion conditions with [n-pentane](#annotation-34){ref-type="annotation"}.

Crystal structure determination
-------------------------------

X-ray intensity data were collected on a Rigaku AFC7 four-circle diffractometer equipped with a Mercury CCD area detector using graphite-monochromated Mo-K~a~ radiation (*λ*=0.71073 Å) at *T*=143 K. All structures were refined to convergence against F^2^ using programs from the SHELX family[@b46]. Selected parameters are summarized in the [Supplementary Tables S3--S5](#S1){ref-type="supplementary-material"} and full details are given in [Supplementary Data 1--8](#S1){ref-type="supplementary-material"}.

The Cambridge Crystallographic Data Center (http://www.ccdc.cam.ac.uk/conts/retrieving.html) hosts the crystallographic data for these compounds. Deposition numbers: CCDC-778896 ([cryptophane-A](#annotation-33){ref-type="annotation"} with [H2O](#annotation-32){ref-type="annotation"}); CCDC-778897 ([cryptophane-A](#annotation-31){ref-type="annotation"} with [Xe](#annotation-30){ref-type="annotation"}); CCDC-778902 (tripropargyl cryptophane **1**, partially occupied); CCDC-778903 (tripropargyl cryptophane **1** with [Xe](#annotation-29){ref-type="annotation"}); CCDC-778898 (triallyl cryptophane **2**, collapsed); CCDC-778899 (triallyl cryptophane **2** with [CDCl3](#annotation-28){ref-type="annotation"}); CCDC-778900 (triallyl cryptophane **2** with [MeOH](#annotation-27){ref-type="annotation"}); and CCDC-778901 (triallyl cryptophane **2** with [Xe](#annotation-26){ref-type="annotation"}). ORTEP representations of eight reported structures are presented as [Supplementary Figure S4a--h](#S1){ref-type="supplementary-material"}.
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    22427

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

n-pentane

:   compound

    OFBQJSOFQDEBGM-UHFFFAOYSA-N

    8003

    7712

diethyl ether

:   compound

    RTZKZFJDLAIYFH-UHFFFAOYSA-N

    3283

    3168

fluorobenzene

:   compound

    PYLWMHQQBFSUBP-UHFFFAOYSA-N

    10008

    9614

chloroform

:   compound

    HEDRZPFGACZZDS-UHFFFAOYSA-N

    6212

    5977

methanol

:   compound

    OKKJLVBELUTLKV-UHFFFAOYSA-N

    887

    864

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

quinine

:   compound

    LOUPRKONTZGTKE-WZBLMQSHSA-N

    3034034

    84989

β-cyclodextrin

:   compound

    WHGYBXFWUBPSRW-FOUAGVGXSA-N

    444041

    10469496

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

water

:   compound

    XLYOFNOQVPJJNP-UHFFFAOYSA-N

    962

    937

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

water

:   compound

    XLYOFNOQVPJJNP-UHFFFAOYSA-N

    962

    937

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

xenon-129

:   compound

    FHNFHKCVQCLJFQ-YPZZEJLDSA-N

    10290811

    8466280

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

xenon-129

:   compound

    FHNFHKCVQCLJFQ-YPZZEJLDSA-N

    10290811

    8466280

xenon-129

:   compound

    FHNFHKCVQCLJFQ-YPZZEJLDSA-N

    10290811

    8466280

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

deuterochloroform

:   compound

    HEDRZPFGACZZDS-MICDWDOJSA-N

    71583

    64654

dichloromethane

:   compound

    YMWUJEATGCHHMB-UHFFFAOYSA-N

    6344

    6104

cryptophane-C

:   compound

    QYIGMWOHVCLMNV-UHFFFAOYSA-N

    11787666

    9962341

chloroform

:   compound

    HEDRZPFGACZZDS-UHFFFAOYSA-N

    6212

    5977

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

chloroform

:   compound

    HEDRZPFGACZZDS-UHFFFAOYSA-N

    6212

    5977

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

chloroform

:   compound

    HEDRZPFGACZZDS-UHFFFAOYSA-N

    6212

    5977

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

tetrachloroethane-d2

:   compound

    QPFMBZIOSGYJDE-QDNHWIQGSA-N

    118531

    105940

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

methane

:   compound

    VNWKTOKETHGBQD-UHFFFAOYSA-N

    297

    291

chloroform

:   compound

    HEDRZPFGACZZDS-UHFFFAOYSA-N

    6212

    5977

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

methane

:   compound

    VNWKTOKETHGBQD-UHFFFAOYSA-N

    297

    291

ethylene

:   compound

    VGGSQFUCUMXWEO-UHFFFAOYSA-N

    6325

    6085

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

cyclotriguaiacylene

:   compound

    WUBWRWRJJNRMPO-UHFFFAOYSA-N

    10960531

    9135747

cyclotriguaiacylene

:   compound

    WUBWRWRJJNRMPO-UHFFFAOYSA-N

    10960531

    9135747

chloroform

:   compound

    HEDRZPFGACZZDS-UHFFFAOYSA-N

    6212

    5977

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

methanol

:   compound

    OKKJLVBELUTLKV-UHFFFAOYSA-N

    887

    864

water

:   compound

    XLYOFNOQVPJJNP-UHFFFAOYSA-N

    962

    937

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

xenon

:   compound

    FHNFHKCVQCLJFQ-UHFFFAOYSA-N

    23991

    22427

cryptophane-A

:   compound

    SQMLCHVWDQRDTG-UHFFFAOYSA-N

    11332002

    9506949

water

:   compound

    XLYOFNOQVPJJNP-UHFFFAOYSA-N

    962

    937

ethylene

:   compound

    VGGSQFUCUMXWEO-UHFFFAOYSA-N

    6325

    6085

Support came from DOD (W81XWH-04-1-0657), NIH (CA110104, CA110104), NSF (CHE-0840438), a Camille and Henry Dreyfus Teacher-Scholar Award, and from the UPenn Chemistry Department.

![Cryptophane hosts used in this study.\
[Cryptophane-A](#annotation-13){ref-type="annotation"}, tripropargyl (**1**) and triallyl (**2**) derivatives are shown as single enantiomers.](ncomms1151-f1){#f1}

![X-ray crystal structures of cryptophanes and inclusion complexes in side view.\
(**a**) [Cryptophane-A](#annotation-12){ref-type="annotation"} with [Xe](#annotation-11){ref-type="annotation"}, and b, with [water](#annotation-10){ref-type="annotation"}, oxygen shaded red; both in CC conformation. (c) Tripropargyl cryptophane (1), with [Xe](#annotation-9){ref-type="annotation"}, and d, partially occupied; both in CC conformation. (e) Triallyl cryptophane (2), with [Xe](#annotation-8){ref-type="annotation"}, in CC conformation. [Xe](#annotation-7){ref-type="annotation"} atom is shaded blue; and f, collapsed, in CS conformation.](ncomms1151-f2){#f2}

![Zoomed view of the Xe-2 complex.\
This highlights van der Waals interactions between phenyl carbon atoms and [xenon](#annotation-6){ref-type="annotation"}. Hydrogen atoms and side chains were removed for clarity. Only [Xe](#annotation-5){ref-type="annotation"} atom and two phenyl groups from opposing [CTG](#annotation-4){ref-type="annotation"} units are depicted with van der Waals radii.](ncomms1151-f3){#f3}

![Side (a) and (b) top views of two superimposed crystal structures of triallyl cryptophane (**2**).\
**2** is shown encapsulating [MeOH](#annotation-3){ref-type="annotation"} (grey) and [CDCl3](#annotation-2){ref-type="annotation"} (pink). Guests, hydrogens and side chains were removed for easier viewing.](ncomms1151-f4){#f4}

![Ethylenedioxy linker of cryptophane-A.\
Both anti and gauche conformations are observed in all crystal structures of cryptophane host--guest complexes.](ncomms1151-f5){#f5}

###### Internal volumes of host molecule cryptophane-A and derivatives 1 and 2, guest volumes, and packing coefficients.

  **Guest**                                        **Host**                                            **Internal volume (Å**^**3**^**)**[\*](#t1-fn1){ref-type="fn"}   **Guest volume (Å**^**3**^**)**   **Packing coefficient**[†](#t1-fn4){ref-type="fn"}
  ------------------------------------------------ -------------------------------------------------- ---------------------------------------------------------------- --------------------------------- ----------------------------------------------------
  \'Collapsed\'                                    CS-**2**                                                                         ---                                               ---                                        ---
  Partial occupancy                                CC-**1**[‡](#t1-fn4){ref-type="fn"}                                               87                                               ---                                        ---
  [H2O](#annotation-25){ref-type="annotation"}     [Crypt-A](#annotation-24){ref-type="annotation"}                                  88                                               18                           0.20[§](#t1-fn4){ref-type="fn"}
  [MeOH](#annotation-23){ref-type="annotation"}    **2**                                                                             84                                               33                                         0.39
  [Xe](#annotation-22){ref-type="annotation"}      **2** (conf. 1)[∥](#t1-fn5){ref-type="fn"}                                        89                                               42                                         0.47
                                                   **2** (conf. 2)[∥](#t1-fn5){ref-type="fn"}                                        87                                               42                                         0.48
                                                   **1**                                                                             85                                               42                                         0.49
                                                   [Crypt-A](#annotation-21){ref-type="annotation"}                                  89                                               42                                         0.47
  [CDCl3](#annotation-20){ref-type="annotation"}   **2** (conf. 1)[∥](#t1-fn5){ref-type="fn"}                                       102                                               72                                         0.71
                                                   **2** (conf. 2)[∥](#t1-fn5){ref-type="fn"}                                        98                                               72                                         0.73

\*Internal volumes were calculated using Deep View/Swiss Pdb Viewer.

^†^Packing coefficient is guest volume divided by host internal volume.

^‡^Diffuse electron density was observed inside the CC-**1** cavity, which cannot be assigned to an encapsulated guest but is likely due to trace [water](#annotation-19){ref-type="annotation"}.

^§^This value is based on one bound [water](#annotation-18){ref-type="annotation"} molecule, whereas partial electron density corresponding to [water](#annotation-17){ref-type="annotation"} in seven different positions was observed.

^∥^Some crystal structures gave two conformers, which differed slightly in the orientations of the side chains and in their calculated internal volumes.

###### Crystallographically determined dihedral angles and conformational assignments of the -O-CH~2~-CH~2~-O- linkers in 1 and 2.

  **Guest**                                        **Host**                                      **Θ 1(°)**[\*](#t2-fn1){ref-type="fn"}**/Conf.**   **Θ 2(°)**[\*](#t2-fn1){ref-type="fn"}**/Conf.**   **Θ 3(°)**[\*](#t2-fn1){ref-type="fn"}**/Conf.**
  ------------------------------------------------ --------------------------------------------- -------------------------------------------------- -------------------------------------------------- --------------------------------------------------
  \'Collapsed\'                                    CS-**2**                                      63.9/gauche                                        −87.7/gauche                                       −63.9/gauche
  Partial occupancy                                CC-**1**                                      72.3/gauche                                        −165.3/anti                                        73.8/gauche
  [MeOH](#annotation-16){ref-type="annotation"}    **2**                                         77.4/gauche                                        171.9/anti                                         74.5/gauche
  [Xe](#annotation-15){ref-type="annotation"}      **2** (conf. 1)[\*](#t2-fn1){ref-type="fn"}   73.4/gauche                                        −167.2/anti                                        −175.8/anti
                                                   **2** (conf. 2)[\*](#t2-fn1){ref-type="fn"}   73.5/gauche                                        −166.9/anti                                        70.7/gauche
                                                   **1**                                         71.9/gauche                                        −164.8/anti                                        73.2/gauche
  [CDCl3](#annotation-14){ref-type="annotation"}   **2** (conf. 1)[\*](#t2-fn1){ref-type="fn"}   75.3/gauche                                        −174.0/anti                                        −171.7/anti
                                                   **2** (conf. 2)[\*](#t2-fn1){ref-type="fn"}   75.0/gauche                                        75.4/gauche                                        −174.0/anti

\*Measured dihedral angles: **Θ 1**: O~2~-C~46~-C~47~-O~3~; **Θ 2**: O~8~-C~56~-C~57~-O~9~; **Θ 3**: O~5~-C~51~-C~52~-O~6~.
